Acumen Pharmaceuticals (ABOS) Earnings Yield: History & Chart

Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The earnings yield is N/A as of 2026-10-06T12:50:18.157Z.

Stored calculation inputs

Calculation as of: 2026-10-06T12:50:18.157Z.

Quote observation: 2026-10-05T20:00:01.000Z. Amounts in USD. The price header may show a later quote.

Unrounded diluted TTM EPS · period ending 2026-06-30: -1.64
Quote price: 2.13

FMP input reference: 5d81df243028a463df18dadfb6b81954a95dec5b5738e9798e17a16434fd93e0

P/E Ratio|FCF Yield|Dividend Yield|All Metrics

ABOS Earnings Yield Metrics

EARNINGS YIELD

N/A

ABOS Competitors' Earnings Yield

ABOS

Acumen Pharmaceuticals, Inc.

Current

Market Cap

$153.84M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

AVXL

Anavex Life Sciences Corp.

vs ABOS

Market Cap

$152.45M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CRDL

Cardiol Therapeutics Inc.

vs ABOS

Market Cap

$152.16M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CDXS

Codexis, Inc.

vs ABOS

Market Cap

$149.51M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

INGN

Inogen, Inc.

vs ABOS

Market Cap

$160.82M

Earnings Yield

N/A

TTM Avg

1.53%

3Y Avg

2.27%

5Y Avg

1.64%

IMRX

Immuneering Corporation

vs ABOS

Market Cap

$146.66M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ALXO

ALX Oncology Holdings Inc.

vs ABOS

Market Cap

$162.82M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

FBIOP

Fortress Biotech, Inc.

vs ABOS

Market Cap

$142.49M

Earnings Yield

14.82%

TTM Avg

16.11%

3Y Avg

16.11%

5Y Avg

16.11%

ACOG

Alpha Cognition Inc

vs ABOS

Market Cap

$142.11M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

FRNM

Freenome, Inc.

vs ABOS

Market Cap

$137.29M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EARNINGS YIELD	TTM	3Y	5Y
Acumen Pharmaceuticals, Inc. (ABOS)	$153.84M	N/A	N/A	N/A	N/A
Anavex Life Sciences Corp. (AVXL)vs ›	$152.45M	N/A	N/A	N/A	N/A
Cardiol Therapeutics Inc. (CRDL)vs ›	$152.16M	N/A	N/A	N/A	N/A
Codexis, Inc. (CDXS)vs ›	$149.51M	N/A	N/A	N/A	N/A
Inogen, Inc. (INGN)vs ›	$160.82M	N/A	1.53%	2.27%	1.64%
Immuneering Corporation (IMRX)vs ›	$146.66M	N/A	N/A	N/A	N/A
ALX Oncology Holdings Inc. (ALXO)vs ›	$162.82M	N/A	N/A	N/A	N/A
Fortress Biotech, Inc. (FBIOP)vs ›	$142.49M	14.82%	16.11%	16.11%	16.11%
Alpha Cognition Inc (ACOG)vs ›	$142.11M	N/A	N/A	N/A	N/A
Freenome, Inc. (FRNM)vs ›	$137.29M	N/A	N/A	N/A	N/A

Earnings Yield vs P/E Ratio

Earnings Yield

N/A

EPS ÷ Price

P/E Ratio

N/A

Price ÷ EPS

Formula: Earnings Yield = (EPS / Price) × 100

Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.

How earnings yield is used:

It expresses earnings relative to share price as a percentage
It can be compared with FCF yield and dividend yield
It can be compared with bond yields because both are percentages
It is mathematically the inverse of the P/E ratio

Earnings Yield Formula & Definition

Earnings Yield = EPS (TTM) / Share Price

Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Earnings Yield: N/A

ABOS Earnings Yield Metrics

ABOS Competitors' Earnings Yield

Earnings Yield vs P/E Ratio

Earnings Yield Formula & Definition

Related Metrics